post-radiotherapy; median age of 48 years) and 27 normal controls (healthy donors; 14 men and 13 women; median age of 49 years) at the Affiliated Hospital of Guangdong Medical University during 2014. Enzyme-linked immunosorbent assay (ELISA) procedures to test serum TGF-1 levels were performed according to the manufacturer's instructions (R&D System, MN, USA). The mean serum level of TGF-1 in untreated NPCs was 1498±334.6 pg/ml, which was significantly higher than that in control samples (1245±305.6 pg/ml) (p < 0.05). However, the mean serum TGF-1 level in NPC samples post-radiotherapy declined to 1201±368.4 pg/ml and was significantly lower than that of the pre-radiotherapy group (p < 0.05). Data were described as mean  SD. Each group in transwell assay and wound healing assay was repeated three wells.
Original magnification for (A), ×200; for (B), ×100. 
